Study of the Efficacy and Multiple-Dose Plasma Concentration-Time Profiles of Armodafinil and PROVIGIL
Public ClinicalTrials.gov record NCT00236080. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study of the Efficacy and Multiple-Dose Plasma Concentration-Time Profiles of Armodafinil (150, 200, and 250 mg) and PROVIGIL® (200 mg) in Patients With Chronic Shift Work Sleep Disorder
Study identification
- NCT ID
- NCT00236080
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Cephalon
- Industry
- Enrollment
- 136 participants
Conditions and interventions
Conditions
Interventions
- Armodafinil 150 mg Drug
- Armodafinil 200 mg Drug
- Armodafinil 250 mg Drug
- PROVIGIL 200 mg Drug
- Placebo Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years to 65 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jul 31, 2005
- Primary completion
- Not listed
- Completion
- Nov 30, 2005
- Last update posted
- Jul 18, 2013
2005
United States locations
- U.S. sites
- 20
- U.S. states
- 15
- U.S. cities
- 19
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Psypharma Clinical Research | Phoenix | Arizona | 85050 | — |
| PsyPharma Clinical Tucson | Tucson | Arizona | 85712 | — |
| Central Arkansas Research | Hot Springs | Arkansas | 71913 | — |
| Pacific Sleep Medicine Service | Los Angeles | California | 90048 | — |
| Pacific Sleep Medicine Service | San Diego | California | 92121 | — |
| BMR HealthQuest | San Diego | California | 92123 | — |
| Stanford University | Stanford | California | 94305 | — |
| Neurotrials Research | Atlanta | Georgia | 30342 | — |
| SLEEPMED, Inc. | Macon | Georgia | 31202 | — |
| Henry Lahmeyer, MD | Northfield | Illinois | 60093 | — |
| Vince and Associates Clinical | Overland Park | Kansas | 66211 | — |
| Center for Sleep/Wake Disorder | Chevy Chase | Maryland | 20815 | — |
| Brigham and Women's Hospital | Boston | Massachusetts | 02115 | — |
| Clinical Rsch Center of Nevada | Las Vegas | Nevada | 89104 | — |
| Clinilabs / Sleep Disorders In | New York | New York | 10025 | — |
| Wake Research Associates | Raleigh | North Carolina | 27612 | — |
| St. Vincent Mercy Medical Cent | Toledo | Ohio | 43608 | — |
| Consolidated Clinical Trials | Pittsburgh | Pennsylvania | 15221 | — |
| SleepMed of South Carolina | Columbia | South Carolina | 29201 | — |
| Radiant Research Salt Lake | Salt Lake City | Utah | 84107 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00236080, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jul 18, 2013 · Synced May 8, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00236080 live on ClinicalTrials.gov.